LITTLE KNOWN FACTS ABOUT PHENOBARBITAL SODIUM WATER SOLUBILITY.

Contraindicated (1)pentobarbital will decrease the level or effect of lumefantrine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration with strong CYP3A4 inducers can lead to diminished serum concentrations and loss of antimalarial efficacyContraindicated (1)pentobarbital will lower the extent or effect of do